Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Rau, Rachel E  [Clear All Filters]
2016
Eckstein OS, Wang L, Punia JN, Kornblau SM, Andreeff M, Wheeler DA, Goodell MA, Rau RE. Mixed Phenotype Acute Leukemia (MPAL) Exhibits Frequent Mutations in DNMT3A and Activated Signaling Genes. Exp Hematol. 2016.
2019
Rau RE, Goodell MA. Measure Twice, Cut Once: Therapeutic Editing of HSPCs Requires Precise Planning. Cell Stem Cell. 2019;24(4):511-512.
2021
Rogers JH, Gupta R, Reyes JM, Gundry M, Medrano G, Guzman A, Aguilar R, Conneely SE, Song T, Johnson CAnthony, et al. Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities. Blood Adv. 2021.
2022
Pinchinat A, Gupta S, Cooper SL, Rau RE. SOHO State of the Art Updates and Next Questions | Optimal Timing of Blinatumomab for the Treatment of B-Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2022.
2023
Kumar P, Zhang N, Lee J, Cheng H, Kurtz K, Conneely SE, Sasidharan R, Rau RE, Pati D. Cohesin Subunit RAD21 Regulates the Differentiation and Self-Renewal of Hematopoietic Stem and Progenitor Cells. Stem Cells. 2023.
Ramabadran R, Wang JH, Reyes JM, Guzman AG, Gupta S, Rosas C, Brunetti L, Gundry MC, Tovy A, Long H, et al. DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells. Nat Cell Biol. 2023.
Chambers C, Cermakova K, San Chan Y, Kurtz K, Wohlan K, Lewis AHenry, Wang C, Pham A, Dejmek M, Sala M, et al. SWI/SNF blockade disrupts PU.1-directed enhancer programs in normal hematopoietic cells and acute myeloid leukemia. Cancer Res. 2023.
2024
Reyes JM, Tovy A, Zhang L, Bortoletto AS, Rosas C, Chen C-W, Waldvogel SM, Guzman AG, Aguilar R, Gupta S, et al. Hematologic DNMT3A reduction and high-fat diet synergize to promote weight gain and tissue inflammation. iScience. 2024;27(3):109122.